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Human immunodeficiency virus type 1 (HIV-1) infection alters the expression of host cell genes at both the mRNA and
protein levels. To obtain a more comprehensive view of the global effects of HIV infection of CD4-positive T-cells at the mRNA
level, we performed cDNA microarray analysis on approximately 1500 cellular cDNAs at 2 and 3 days postinfection (p.i.) with
HIV-1. Host cell gene expression changed little at 2 days p.i., but at 3 days p.i. 20 cellular genes were identified as
differentially expressed. Genes involved in T-cell signaling, subcellular trafficking, and transcriptional regulation, as well as
several uncharacterized genes, were among those whose mRNAs were differentially regulated. These results support the
hypothesis that HIV-1 infection alters expression of a broad array of cellular genes and provides a framework for future
functional studies on the differentially expressed mRNA products. © 2000 Academic Press
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uViruses, such as human immunodeficiency virus type 1
(HIV-1), impact on a diverse set of the host cell’s biochem-
ical processes. For example, viral infection induces the
interferon antiviral response (1, 2), modulates expression of
ell surface molecules, and manipulates the cell’s tran-
criptional, translational, and trafficking machinery (3).
any of these interactions will be characterized by
hanges in cellular mRNA levels that will depend on both
he stage of infection and the biological state of the infected
ell. The recent emergence of high-density DNA arrays
microarrays or oligonucleotide chips) has revolutionized
ene expression studies by providing a means to measure
RNA levels for thousands of genes simultaneously [for
eview see (4–6)]. The potential of this technology for inves-
igating viral–host cell interactions has yet to be realized, as
t has only recently been applied to a viral infection (7). Here
e used cDNA microarray technology to examine HIV-1-
AI infection of the CD41 T-cell line CEM-CCRF in order to
dentify cellular genes influenced by viral infection. In addi-
ion, custom software was developed to quantitatively an-
lyze the microarray data. We have identified 20 cellular
RNAs from a variety of cellular pathways, whose levels
re altered by HIV-1 infection.
1 To whom correspondence and reprint requests should be ad-
ressed at Department of Microbiology, School of Medicine,
ox 357330, Seattle, WA 98195. Fax: (206)-685-0305. E-mail: honey@
.washington.edu.
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8Results. Differential expression of host cell genes in
IV-1-infected CEM cells was investigated with the use
f cDNA microarray analysis. Polyadenylated RNA was
solated from mock- and HIV-1-infected cells at 2 and 3
ays p.i. Earlier work from our laboratory has demon-
trated that by 2 days p.i. approximately 80% of the cells
ere infected and by 3 days p.i. more than 95% of the
ells were infected under the experimental conditions
tilized (8). Poly(A)1 mRNAs were reverse transcribed in
the presence of either Cy3- or Cy5-labeled dCTP to
produce fluorescently labeled first-strand cDNAs. The
mock-infected sample was labeled with Cy3 and the
HIV-1-infected sample was labeled with Cy5. To reduce
potential biases in labeling and hybridization due to
characteristics of the particular Cy-labeled dCTP, this
labeling scheme was reversed in half of the experiments
(i.e., mock-infected Cy5 and HIV-1-infected Cy3 cells).
The appropriate samples were combined and hybridized
to replicate slides. All slides were made with duplicate
sets of 1506 target cDNAs on the left- and right-hand
sides of the array. The microarrays were scanned with a
dual-laser scanning confocal microscope (Molecular Dy-
namics) producing two images, each corresponding to
one-half of the slide. A pseudo-color image of the hybrid-
ization results for the entire 1506 gene set in each label-
ing scheme is shown (Fig. 1A). A magnified view of one
section of replicate microarrays hybridized with samples
from both 2 (Fig. 1B) and 3 (Fig. 1C) days p.i. is also
nd.
9RAPID COMMUNICATIONshown. The entire data set consists of four replicate
microarrays (two in each color scheme) for 2 days p.i.
and two replicate microarrays for 3 days p.i. (one in each
color scheme), resulting in eight and four separate mea-
surements per gene for days 2 and 3 p.i., respectively.
The amount of a given mRNA in each sample was
determined by measuring the Cy3 and Cy5 signal of each
spot after scanning the microarray at 532 and 633 nm,
respectively. The raw data were collected, normalized,
and statistically analyzed using the custom software as
T
List of Different
Accession
No. Putative gene ID
Upregu
AA427491 T-cell receptor a-chain, c region
AA443584 CD8-a precursor
AA455278 Human neurogranin
AA458503 Receptor-interacting protein 140 (
AA457123 Transfer valyl-tRNA synthetase
AA457118 hTOM34 translocase
AA290698 IMAGE ID 700414
H47026 IMAGE ID 178468
AA455695 IMAGE ID 813990
Downre
AA455931 Adenylosuccinate lyase
M26708 Prothymosin alpha
L00160 Phosphoglycerate kinase
AA401111 Glucose phosphate isomerase
AA621300 p18 protein mRNA/stathmin
AA463631 Signal recognition particle 72
AA399473 Placental protein 5 (PP5)
AA504327 Type IVA protein tyrosine phosph
U34379 Txk kinase
AF038953 E25 mRNA (clone 1)
E25 mRNA (clone 2)
Note. ND, not determined due to insufficient signal above backgrou
FIG. 1. Pseudo-color image from a cDNA microarray hybridized with
results for the complete set of 1506 genes hybridized with labeled
mock-infected sample was labeled in Cy3 (represented in green) and
scheme was reversed in the right-hand side of A. (B) A section of a m
2 days p.i. Arrows indicate cDNA clones corresponding to the follow
prothymosin-a, (5) TCR-a, and (6) CD8-a. The labeling scheme was ex
B, except RNA was isolated from cultures 3 days p.i. Genes expressed
expressed genes will appear as shades of either red or green. The br
cell populations.
FIG. 2. Comparison of ratio values for 200 highly expressed genes. A
of the most highly expressed cellular genes. Day 2 ratios are shown
identifications for several differentially expressed genes are indicated.
below 1. A value of 0.5 is equal to a twofold downregulation with respec
FIG. 3. Differential expression of select cellular genes. (A) Individual
infection. Twenty micrograms of total RNA from HIV-1-infected (H) or m
PCR products that were spotted on the microarray. In all cases the signal wa
2 and 3 days p.i. (data not shown). The labeling scheme used is indicated. (Boutlined in the Appendix. Using a strategy similar to that
described by Chen and colleagues, differentially ex-
pressed genes were selected based on the distribution
of the ratios at each time point [(9) and see Appendix].
The list of differentially expressed genes that are greater
than 1.5-fold up- or downregulated is presented in Table
1. Those mRNAs with high relative errors in the ratio
(greater than 25%) or containing repeated elements were
excluded from this list. The majority of differences in
gene expression were observed at day 3 p.i., with 17 of
pressed Genes
Fold change
(2-day PI)
Fold change
(3-day PI)
enes
1.19 6 0.14 3.13 6 0.77
0.99 6 0.14 1.63 6 0.24
1.02 6 0.07 1.68 6 0.24
) 0.84 6 0.10 1.74 6 0.17
0.89 6 0.13 1.68 6 0.14
1.03 6 0.13 1.82 6 0.12
1.21 6 0.14 2.23 6 0.27
0.93 6 0.16 1.52 6 0.11
1.10 6 0.09 1.66 6 0.25
genes
1.00 6 0.21 0.65 6 0.02
0.81 6 0.14 0.48 6 0.04
1.17 6 0.21 0.58 6 0.13
1.04 6 0.07 0.51 6 0.04
0.95 6 0.12 0.60 6 0.10
0.66 6 0.16 ND
ND 0.67 6 0.09
0.83 6 0.13 0.57 6 0.06
0.65 6 0.15 ND
1.21 6 0.13 0.57 6 0.04
1.15 6 0.08 0.61 6 0.06
scent probes from mock- and HIV-1-infected samples. (A) Microarray
and HIV-1-infected cDNAs 3 days p.i. On the left-hand side of A,
fected sample was labeled in Cy5 (represented in red). This labeling
y containing 512 cDNAs hybridized with probes generated from cells
es: (1) GFP control, (2) HIV-1 pol gene, (3) ribosomal protein L21, (4)
described for A. (C) The same section of the microarray as shown in
al levels in both cell populations will appear yellow, while differentially
s of each spot reflects the relative abundance of that gene in the two
lot of the normalized ratio with errors (one standard deviation) for 200
diamonds, and day 3 ratios are shown by red squares. The putative
lated genes are above 1 on the y-axis and downregulated genes are
V-infected cells. Genes believed to be of special interest are indicated.
rray and Northern blot results for several genes upregulated by HIV-1
cted (M) cells 3 days p.i. was hybridized with probes derived from theABLE 1
ially Ex
lated g
RIP140
gulated
atasefluore
mock-
HIV-1-in
icroarra
ing gen
actly as
at equ
ightnes
line p
by blue
Upregu
t to HI
microa
ock-infe
s normalized to the ribosomal L21 gene that was unchanged at both
) The same analysis was performed for several downregulated genes.
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12 RAPID COMMUNICATION20 genes being differentially regulated exclusively at this
time point. The reproducibility and accuracy of our mea-
surements were further supported by the fact that two
independent cDNAs of the same gene, the putative inte-
gral membrane protein, e25, were downregulated to the
same extent in both cases (Table 1 and Fig. 2).
Given that expression level measurements showing
only 1.5-fold differences may not be considered signifi-
cant in more traditional biological measurements (e.g.,
Northern or Western analyses), it was important to dem-
onstrate that the 1.5-fold differences were statistically
significant. The normalized expression ratios for the 200
most highly expressed genes were plotted with error
bars in Fig. 2. On the same graph, horizontal lines indi-
cate 1.5-fold expression changes in both directions. This
graph clearly shows that most of the selected genes
were outside the norm not only in their expression ratios
but also by more than the variation of the measurements
and labeling processes (indicated by error bars). Indeed,
from the data it is apparent that expression ratios as low
as 1.2 or 1.3 can be statistically meaningful. In addition,
the microarray ratios may be underestimated when com-
pared with more traditional approaches such as North-
ern blot (Fig. 3).
A set of up- and downregulated clones were selected
for confirmation by Northern blots. The array data in both
color schemes are shown with the corresponding North-
ern blots (Figs. 3A and 3B). Upregulated genes are rep-
resented as a red spot when an HIV-1-infected sample
was labeled with Cy5 and green when labeled when Cy3
(compare upper and lower spots in Fig. 3A). Downregu-
lated genes exhibited the opposite pattern when labeled
the same way (compare upper and lower spots in Fig.
3B). Northern blots were performed using the cDNA
clone that was spotted on the array. In six of the seven
clones tested, the Northern blots were consistent with
microarray results (Fig. 3 and see below for exception).
The estimated sizes for mRNA species for these six
genes were as follows: nuclear receptor interacting pro-
tein 140 (RIP140) (1.7 and 3.8 kb), TCR-a (1.7 kb), TOM34
1.8 kb), prothymosin-a (1.2 kb), and type IV protein ty-
rosine phosphatase (PTP) (1.8 and 4.5 kb). These sizes
corresponded well with published results, with the ex-
ception of RIP140. We observed two mRNA species of
sizes (above) neither of which agree with the 7.5-kb
transcript reported in human breast cancer line ZR75-1
(10). Finally, the type IV PTP, a human homologue of rat
PRL-1 (11), also exhibited two mRNA species, both of
which were downregulated by Northern blot. The largest
mRNA reported in humans is approximately 1.5 kb, which
may correspond to the smaller mRNA species seen in
our experiments. The larger mRNA may represent an
alternative polyadenylation signal, as reported for the rat
gene or one of several PRL-1 homologues (12, 13). In
general, changes determined by Northern blot were
greater than those determined by microarray. The
c
tchanges by Northern analysis (normalized to ribosomal
protein L21) for the selected genes were as follows:
RIP140 (.5 upper and lower), TCR-a (4.4), TOM34 (2.2),
prothymosin-a (7), and type IV PTP (2.9 upper, 1.8 lower).
Given these results and the reproducibility of the mi-
croarray experiments, genes with ratios as low as 1.3- or
1.4-fold are likely to be worth further investigation.
Of the genes tested, only thymosin-b10 could not be
erified by Northern analysis. This result was somewhat
nexpected because this gene seemed to be consis-
ently and significantly regulated at both 2 and 3 days p.i.
Table 1 and Fig. 2). Control experiments (Northern blots
nd microarray hybridizations with the full length HIV-1
enome, not shown) indicated that this gene cross-hy-
ridized with viral sequences, resulting in a false-posi-
ive signal. No other upregulated cellular gene listed in
able 1 was found to cross-hybridize to viral sequences.
hese results indicate that cross-hybridization could be
potential problem in experimental systems in which
bundant exogenous RNA species are present (e.g., viral
r bacterial infections) and appropriate confirmatory
teps must be taken to avoid false positives.
Discussion. We have examined the expression of 1506
DNAs during HIV-1 infection of CEM cells using cDNA
icroarrays and identified 20 differentially expressed
enes that function in a variety of cellular pathways.
hese results support the hypothesis that HIV-1 infection
lters cellular gene expression at a global level that has
ot been recognized previously. To our knowledge, this
tudy is the first quantitative large-scale analysis of host
ell gene expression in HIV-1-infected cells and further
emonstrates the usefulness of microarray technology in
he study of pathogenic viruses. In addition, we have
eveloped methods to quantitate and analyze microarray
mages that can be used in our subsequent studies of
iral–host cell interactions. Although published data on
eproducibility and error analysis are limited, we believe
he analysis methods used for this system will be trans-
erable to other array systems and technologies. Regard-
ess, users are cautioned to perform appropriate statis-
ical analyses before pursuing leads based on apparent
ifferential expression ratios because of a large number
f false-positive results from lowly expressed genes with
igh, effectively meaningless ratios.
The differentially expressed genes identified in this
tudy have been reported to function in a variety of
ellular processes including T-cell receptor-mediated
ignaling, subcellular trafficking, transcriptional regula-
ion, and a variety of cellular metabolic pathways. In
ddition, several ESTs and as yet uncharacterized
RNAs were influenced by HIV-1 infection. Presumably,
ome of these genes will play a role in the host cell
efense mechanisms and/or facilitation of the viral life
ycle. Several genes are worth commenting on, given
heir association with HIV or other viral infections or their
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13RAPID COMMUNICATIONknown roles in cellular regulatory pathways that have the
potential to be influenced by viral infection.
T-cell Interactions. Several of the differentially ex-
pressed genes are known to participate in T-cell inter-
actions. The mRNAs for the T-cell receptor-a chain and
CD8-a, both involved in recognition of antigen via inter-
ction with MHC molecules, were upregulated at day
p.i. increasing from barely detectable at day 2 p.i. to
ifferentially expressed at 3 days (compare arrows 5 and
, Figs. 1B and 1C). Although the functional significance
f this observation is not yet known, it could partially
ccount for populations of HIV-1-infected CD81 cells in
nfected individuals (14) or the increase in CD81 cell
ounts observed in some patients (15). The mechanisms
f CD8 regulation under these experimental systems are
ot known and could be mediated directly by HIV-1
roteins or indirectly through modulation of cytokine pro-
uction by HIV-1-infected cells. Other interesting differ-
ntially expressed genes (in the context of T-cell signal-
ng) include the Txk kinase (16), a member of the Tec
amily of protein kinases, and the recently identified type
VA PTP (17), similar to rat PRL-1 (13).
Cellular Trafficking/Transport. Translocase of the outer
embrane (TOM34), a newly identified member of the
itochondrial transport machinery (18), was found to be
pregulated 1.8-fold at day 3. In addition to its role in
itochondrial import, TOM34 is a putative member of the
etratricopeptide repeat (TPR) family of proteins (19).
iven that the HIV-1 proteins Vpu and Gag have been
hown to interact with a cellular TPR-containing Vpu
inding protein (UBP) (20), it may be interesting to exam-
ne TOM34 for similar interactions.
Another cellular gene regulated by HIV-1 with a poten-
ial role in cellular trafficking (21) is Prothymosin-a. In-
erestingly, this evolutionary conserved and widely dis-
ributed acidic protein has been shown to interact in vitro
ith the leucine motif activation domain of HIV-1 Rev (22),
viral protein involved in nuclear export of unspliced
iral RNAs [for review see (3)]. Since both rev and pro-
hymosin-a may be involved in nuclear export and/or
shuttling, this physical interaction could be of functional
importance. Therefore, the downregulation of this gene
in the context of HIV-1 infection is worth further investi-
gation. For instance, will high levels of prothymosin-a
inhibit HIV-1 replication, possibly by sequestering and
inactivating the viral rev protein?
Transcriptional Regulation. The transcriptional regula-
or RIP140 (10) was found to be upregulated at 3 days
ost-HIV-1 infection. RIP140 is now considered a cofac-
or for several members of the nuclear receptor super-
amily and is a negative regulator of peroxisome prolif-
rator-activated receptor (PPAR)-mediated transcription23). Since PPAR controls expression of several genes
nvolved in lipid metabolism, these results could suggest cthat lipid metabolism is perturbed in HIV-1-infected cells.
Given the problem of dorsocervical fat pad enlargement
(buffalo hump, especially in HIV-infected patients that
have not been exposed to protease inhibitor therapy)
(24), this should be vigorously investigated. Alternatively,
RIP140 may be recruited to participate in the regulation
of transcription from the viral LTR, since several groups
have reported nuclear receptor binding sites in the HIV-1
LTR, including PPAR (25). Of course, additional studies
will be required to obtain a more complete global per-
spective on the effects of HIV-1 infection on host cell
gene expression. However, by examining a variety of
HIV-1 infection systems, including different viral strains
or cell types, more complete time courses, and larger
sets of human genes, certain pathways will emerge as
playing critical roles during viral infections.
Materials and Methods. HIV-LAI viral stock, CEM cells,
and the conditions for infection were as described previ-
ously (8). Cell viability was determined by trypan blue dye
exclusion and percentage infection confirmed by immuno-
fluorescence assay (IFA) [(8) and data not shown].
Human cDNA IMAGE clones were purchased from
Research Genetics (Huntsville, AL; UG Build No. 18 V5.0,
Plate Nos. 501–505, 511–514, and 516–520 R2). cDNA
inserts for IMAGE clones and controls were PCR ampli-
fied, precipitated, and purified.2 DNA pellets were sus-
pended in a 50% solution of Reagent D (proprietary
solution, Amersham–Pharmacia Biotech, Buckingham-
shire, England) and deposited on 75 3 25-mm coated
glass microscope slides (Amersham Type 4, Type VP)
with the use of a Molecular Dynamics (Sunnyvale, CA)
“Generation II” Microarray Spotter II. After spotting, mi-
croarrays were air-dried, cross-linked at 450 mJ, and
stored desiccated under N2 until needed.
The GFP constructs used for construction of target cDNA
and in vitro synthesized GFP poly(A)1 RNA were kindly
rovided by Dr. Pete Nelson (Department of Molecular
iotechnology, University of Washington). GFP cDNA was
mplified by PCR and deposited at predetermined positions
n the microarray. GFP poly(A)1 RNA was generated by in
vitro transcription of 0.5 mg of template DNA (plasmid
SP64-GFP linearized with EcoRI) using SP6 RNA polymer-
se (Gibco BRL, Gaithersburg, MD) as described in the
anufacturer’s protocol. In vitro transcribed GFP poly(A)1
was added to both RNA samples as a control prior to
reverse transcription (see below).
Total RNA was extracted and Northern blots were
carried out as described previously (8). Total RNA was
treated with RNase-free DNAse I and extracted with
phenol/chloroform, and poly(A)1 mRNA was isolated by a
ingle pass over an oligo(dT) cellulose column (Collab-2 Detailed protocols on PCR amplification and purification and a
omplete list of control and IMAGE cDNAs are available upon request.
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14 RAPID COMMUNICATIONorative Biomedical Products). Fluorescent-labeled cDNA
probes were generated by reverse transcription (RT) as
follows: 1 mg of poly(A)1 RNA from mock- and HIV-
infected cells, 5 ng of GFP poly(A)1 RNA, and 8 pmol of
anchored dT primer (Amersham) were combined in a
10.5-ml reaction volume. The solution was heated to
0°C for 10 min, chilled briefly on ice, and centrifuged.
everse transcription was performed in a 20-ml reaction
volume. Final concentrations were 13 First Strand Buffer
(Gibco BRL), 10 mM DTT, 50 nM dATP/dGTP/dTTP, 6.25
nM nonlabeled dCTP, 6.25 nM FluoroLink-dCTP (either
Cy3 or Cy5 labeled, Amersham), 0.5 units/ml placental
RNase inhibitor (Amersham), and 10 units/ml Superscript
II RT (Gibco, BRL). The contents were mixed and incu-
bated at 42°C for 2 h. RNA was removed by heating the
sample to 94°C for 3 min followed by treatment with
sodium hydroxide (0.25 N final) for 10 min at 37°C. The
sample was neutralized by addition of an equal amount
of HCl, followed by 1 M Tris (pH 7.5) to 0.2 M. Unincor-
porated nucleotides were removed using 96-well multi-
FIG. A1. Reproducibility of the ratio measurement for the 100 most ab
were normalized as described in the text. The normalized ratio value
superimposed on the line plot. Data points were taken from duplicate sp
schemes. Each data set is indicated by a different color line.screen FB filter plates (Millipore).
Prior to hybridization, microarrays were rinsed briefly indeionized H2O and dried with spectroscopy-grade isopro-
panol to remove residual dust. Fluorescently labeled first-
strand cDNAs were concentrated by drying and resus-
pended in 20 ml of 13 hybridization solution [53 SSC, 53
enhardt’s solution, 1% SDS, 50% formamide, 0.1 mg/ml
denatured salmon testes DNA, and 20 mg/ml poly(A)72]. The
ppropriate Cy3- and Cy5-labeled probes were combined,
enatured by boiling, and applied to the microarray under a
2 3 64-mm glass coverslip. Microarrays were incubated
t 42°C in a custom-built humidified chamber for 16–20 h.
icroarrays were washed once in 23 SSC/0.1% SDS at
7°C for 5 min, once in 0.23 SSC/0.1% SDS at room tem-
erature for 5 min, twice in 0.13 SSC at room temperature
or 2 min each, and once with deionized H2O for 10 s. Slides
ere then dried under nitrogen and scanned with a con-
ocal dual-laser scanner at 532 and 633 nm (Molecular
ynamics).
APPENDIX
Image Processing, Data Normalization, and Error Analysis. An impor-
t cDNAs. The ratios for duplicate spots from four separate microarrays
is) for the 100 most abundant cDNAs (x-axis) 2 days p.i. are shown
four separate microarrays hybridized with probes using both labelingundan
s ( y-axtant issue for successful use of microarrays in examining biological prob-
lems is data analysis. As pointed out previously (9, 26), a focus of the data
s
(
c
r
15RAPID COMMUNICATIONanalysis should be to generate both expression ratios and estimates of
uncertainties in these ratios. We have developed custom array analysis
software (E. Hammersmark and R. Bumgarner, in preparation) in order to
provide estimates of error in the ratios for each independent analysis.
Briefly, the software finds the spots in a composite image constructed from
the normalized sum of both color channels, extracts the intensity data from
both color channels by integrating in a circle around each spot center,
determines the local background and variance in local background by
measuring intensity in several locations around each spot, and estimates
the error in the ratio by determining the ratio in several regions of the spot
FIG. A2. Error analysis for all 1536 cDNAs as a function of overall
ignal intensity. The standard deviation of the ratio for each clone
y-axis) was plotted against the sum of intensity for the Cy3 and Cy5
hannels (x-axis), n 5 8. Data represent the cumulative results for
experiments on day 2 p.i., n 5 8. The minimal threshold value of 13,000
elative intensity units is indicated by the dashed line.
FIG. A3. Distribution of ratio values 2 and 3 days p.i. A histogram r
intensity. Dashed lines indicate the cut-off ratio of 1.5-fold, correspon
downregulated genes). Day 2 ratios are shown by hatched bars; day 3 rati
downregulated ratios are shown as the negative inverse values of the normaand calculating a standard deviation. Each image is analyzed indepen-
dently to produce expression ratios and error estimates in these ratios.
This allows us to discard data of low confidence based on a single spot
on the array and to investigate the reproducibility of the arrays across
multiple repeated measurements.
The image analysis produces nonnormalized expression ratios, e.g.,
the output is the intensity of (Cy3 signal minus background) divided by
(Cy5 signal minus background), and is uncorrected for labeling or fluores-
cence detection efficiencies and for relative mRNA concentrations. It is
common practice to normalize data of this type by dividing by a linear
scaling factor, such as a set of “housekeeping” genes, so that these
expression ratios are set to 1. From our data (day 2 p.i., n 5 8) it was
apparent that the Cy3 signal did not increase with concentration at the
same rate as the Cy5 signal under normal hybridization conditions (data
not shown). That is, a linear normalization based on the housekeeping
genes overcorrected the Cy3 signal at lower signal levels. Hence, we
developed an algorithm to normalize the data with a factor that varied as
a function of intensity (R. E. Bumgarner and E. Hammersmark, in prepa-
ration). The net result of this normalization procedure is that the eight
measurements of the data sets on day 2 p.i. agree within 10% relative error
for the 100 most highly expressed genes and within 15% relative error for
the 500 most highly expressed genes (Fig. A1 and data not shown). The
data obtained from day 3 p.i. were treated in the same manner.
The data sets for experiments on days 2 and 3 p.i. were normalized
and combined to produce an average expression ratio and standard
deviation for both data sets. The standard deviation was plotted as a
function of expression level (defined as the sum of the signal in both
color channels) and used to set a threshold intensity below which we
have little confidence in the expression ratios (Fig. A2). An intensity
cutoff was chosen such that the relative error in the ratios was less
than 25%. This intensity cutoff also corresponded well with the lower
limit of what we could confirm by visual reinspection of the array
nts the distribution of ratios for genes above the minimum threshold
approximately the 5th and 95th percentiles (the top 5% of up- andeprese
ding toos are displayed by solid gray bars. For the purpose of this graph,
lized ratio.
16 RAPID COMMUNICATIONimages. In our data set, 477 cDNAs at day 2 p.i. and 436 cDNAs at day
3 p.i. exhibited hybridization signals above their respective minimum
threshold intensities at each time point. The remainder of the cDNAs
(roughly two-thirds of the spotted clones) did not produce data with
sufficient signal-to-noise ratios to be analyzed accurately. Our study
examined a total of about 1500 genes, of which ;30% produced
acceptable signals above threshold.
To assess the validity of our analysis, we examined the normalized
ratios for sets of control genes. As expected, the average ratios for the
GFP control gene and a set of 15 housekeeping genes were close to 1;
for example, see arrow 1 (GFP) and arrow 3 (ribosomal protein L21) in
Fig. 1. Conversely, the HIV-1 cDNAs, used as a positive control for
upregulated genes, showed average changes between 13- and 32-fold
for days 2 and 3 p.i., respectively (Fig. 1, arrow 2).
Selection and Identification of Differentially Expressed Genes. The
frequencies of the HIV-1/mock expression ratios for cellular genes on
days 2 and 3 p.i. are plotted in a histogram in Fig. A3. Differentially
expressed genes that lie in the upper and lower 4% of the histogram,
i.e., the genes that were the most differentially expressed, were se-
lected. This corresponded to ratios that were approximately 1.5-fold up-
or downregulated. It is clear from this histogram that gene expression
remains relatively constant at the day 2 time point, with most genes
clustered around 1.2-fold in either direction. In contrast, the distribution
of ratios at day 3 is more varied, with multiple outliers exhibiting ratios
greater than 1.5-fold.
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